BACKGROUND: Prostate carcinoma patients (PCP) with mental disorders suffer frequently from a decreased quality of life (QOL) and often need psychooncological treatment (PTN). To meet that need, the extent of treatment required should be determined and a reliable identification routine implemented. METHODS: A total of 103 PCP were interviewed with a validated instrument (SCID) during urological inpatient treatment to assess mental disorders of PTN, and questionnaires were administered to examine QOL (QLQ-C30) and mental stress (HADS); 17 doctors and 23 nurses assessed their patients' PTN. RESULTS: Twenty percent of the patients had a PTN which was identified by doctors and nurses in 50% of the cases and by HADS in up to 84%. Even 1 year after treatment, the QOL of patients with PTN was diminished, while patients without recovered remarkably better. CONCLUSION: Patients with PTN should be detected as a matter of routine, e.g., using the HADS, and treated early.
BACKGROUND:Prostate carcinomapatients (PCP) with mental disorders suffer frequently from a decreased quality of life (QOL) and often need psychooncological treatment (PTN). To meet that need, the extent of treatment required should be determined and a reliable identification routine implemented. METHODS: A total of 103 PCP were interviewed with a validated instrument (SCID) during urological inpatient treatment to assess mental disorders of PTN, and questionnaires were administered to examine QOL (QLQ-C30) and mental stress (HADS); 17 doctors and 23 nurses assessed their patients' PTN. RESULTS: Twenty percent of the patients had a PTN which was identified by doctors and nurses in 50% of the cases and by HADS in up to 84%. Even 1 year after treatment, the QOL of patients with PTN was diminished, while patients without recovered remarkably better. CONCLUSION:Patients with PTN should be detected as a matter of routine, e.g., using the HADS, and treated early.
Authors: H Ryan; P Schofield; J Cockburn; P Butow; M Tattersall; J Turner; A Girgis; D Bandaranayake; D Bowman Journal: Eur J Cancer Care (Engl) Date: 2005-03 Impact factor: 2.520
Authors: M Keller; S Sommerfeldt; C Fischer; L Knight; M Riesbeck; B Löwe; C Herfarth; T Lehnert Journal: Ann Oncol Date: 2004-08 Impact factor: 32.976
Authors: Bryan A Weber; Beverly L Roberts; Martin Resnick; Gary Deimling; Jaclene A Zauszniewski; Carol Musil; Hossein N Yarandi Journal: Psychooncology Date: 2004-01 Impact factor: 3.894
Authors: Bernd Löwe; Kerstin Gräfe; Stephan Zipfel; Robert L Spitzer; Christoph Herrmann-Lingen; Steffen Witte; Wolfgang Herzog Journal: J Psychosom Res Date: 2003-12 Impact factor: 3.006